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Abstract
Background: Genetic variation is thought to contribute to the etiology of hypertension, and E-selectin is a
candidate essential hypertension-associated gene. This study thus sought to investigate possible genetic
associations between the T1880C, C602A and T1559C polymorphisms of E-selectin and essential hypertension.
Methods: Hypertensive patients (n = 490) and healthy normotensive subjects (n = 495) were screened for the
genotypes T1880C, C602A and T1559C using real-time quantitative polymerase chain reaction after DNA extraction
to identify representative variations in the E-selectin gene. The associations between genotypes and alleles of the
three mutations and essential hypertension were then analyzed using a case-control study.
Results: Hypertensive patients and normotensive subjects were significantly different with respect to the
genotypes CC, CA and AA (P = 0.005) and the C-allele frequency of C602A (P = 0.001). A comparison of dominant
versus recessive models also revealed significant differences between the two groups (P = 0.004 and P = 0.02).
When subgrouped by gender, these indexes differed significantly between normotensive and essential
hypertensive males, but not in females. The additive model of the T1559C genotype did not differ between
essential hypertensive and normotensive groups overall (P = 0.39), but it was different between hypertensive and
normotensive males (P = 0.046) and females (P = 0.045). The CC + TC versus TT frequency of T1559C was also
different in the recessive model of male hypertensive and normotensive groups (P = 0.02). Further analysis showed
that C602A and T1559C were significantly associated with hypertension (C602A: OR = 7.58, 95%CI = 1.53-11.97,
P < 0.01; and T1559C: OR = 6.77, 95%CI = 1.07-1.83, P < 0.05). The frequency of the C-C-C haplotype was
significantly higher in hypertensive patients than in control individuals as well as in hypertensive and normotensive
males (P = 0.008 and 0.01). The frequency of the C-A-T haplotype was higher only in male hypertensives and
normotensives (P = 0.015). Furthermore, there was a significant interaction between E-selectin and gender
(P = 0.02 for C602A and 0.04 for T1559C).
Conclusion: C602A and T1559C may be independent risk factors for essential hypertension in the Chinese
population, whereas T1880C is not.
Background
E-selectin (SELE, CD62E, ELAM-1), an 11-kD cell sur-
face glycoprotein, is an adhesion molecule of the selectin
family that mediates the interaction of circulating leuko-
cytes with the vascular endothelium in various physiolo-
gical and pathological settings [1]. Its corresponding
gene SELE is located on human chromosome 1. Unique
among other selectin family molecules, E-selectin typi-
cally is not detected in inactivated endothelial cells, but
is rapidly synthesized in response to certain cytokines
and other pro-inflammatory stimuli, making it a marker
of the “activated” endothelial phenotype [2]. Leukocyte-
endothelial interactions contribute to a variety of
vascular disease processes, such as acute and chronic
inflammation and atherosclerosis. Several soluble factors
(e.g., cytokines, chemokines, and growth factors), as well
as cell surface adhesion molecules, which are expressed
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complex fashion to efficiently mediate leukocyte recruit-
ment [3,4].
Several recent findings regarding the genetic back-
ground of atherosclerosis patients have indicated that
DNA polymorphisms in genes that encode adhesion
molecules may be associated with a high risk of severe
atherosclerosis [5,6]. Moreover, recent studies in a Ger-
man population showed possible associations between
the S128R and L554F variations of the E-selectin gene
and severe atherosclerosis, hypertension and cerebrovas-
cular diseases [7,8].
Because E-selectin is related to inflammation and
atherosclerosis, and essential hypertension is character-
ized by chronic inflammation and atherosclerosis, we
attempted to explore the association between E-selectin
single nucleotide polymorphisms (SNPs) and hyperten-
sion. Three candidate SNPs of E-selectin involved in the
pathogenesis of inflammation and atherosclerosis–
T1880C, C602A, T1559C–were selected a priori on the
basis of a genetic analysis, a literature review [9,10], pre-
dictive analyses with an emphasis on functionally impor-
tant variants, and expert opinion. These variants may
provide clues to the pathogenesis of essential
hypertension.
Methods
Study population
All normotensive participants and hypertensive patients
were screened at the physical examination center and
hypertension clinic at Anzhen Hospital. A total of 495
healthy, normotensive subjects (NT group) and 490
hypertensive patients (EH group) were screened. Blood
pressure (BP) was accurately measured three times on
different days with a mercury sphygmomanometer by
experienced internists in their office. Measurements
were taken after the patients had been seated on a chair
with their feet on the floor and their arms supported at
heart level for 10 min. The definition of normotension
(SBP < 130 mmHg and DBP < 85 mmHg) and hyperten-
sion (140 ≤ SBP ≤ 179 mmHg, or 90 ≤ DBP ≤ 109
mmHg) were based on the BP classification of the
seventh report of the Joint National Committee on Pre-
vention, Detection, Evaluation, and Treatment of High
Blood Pressure (JNC-VII). All hypertensive patients
were diagnosed as having essential hypertension and
had never been treated with any antihypertensive drugs.
No hypertensive patients were suffering from any
known diseases, including secondary hypertension, dia-
betic disease or kidney diseases, that might affect BP. BP
was measured according to JNC-VII standards. This
study complied with the Declaration of Helsinki. All
participants signed a consent form, and the study was
approved by the Hospital Ethics Committee [11].
DNA preparation
With the subject in the sitting position, a 5-mL periph-
eral venous blood sample was drawn into an EDTA-Na
anti-coagulated vacutainer tube with minimal use of a
tourniquet. DNA was extracted using the PURGENE kit
from Gentra Systems (Minneapolis, MN, USA) and
stored at -20°C in aliquots until required.
Detection of genotype
The C_11975323_20 (T1880C) SNP genotyping kit was
obtained from Applied Biosystems. The kit contained
two flanking primers as well as C- and T-specific probes
labeled with VIC and FAM fluorescent dyes, respec-
tively. Genotyping reactions contained 1× TaqMan® PCR
Master Mix, No AmpErase® UNG, and approximately 5
ng of genomic DNA in a final volume of 5 μL. Amplifi-
cations were performed using a 7300 Real-Time PCR
System and the following thermocycling conditions:
initial denaturation and activation at 95°C for 10 min-
utes, followed by 40 cycles of 95°C for 15 seconds and
60°C for 1 minute. The genotypes C602A and T1559C
were detected using the SNP kits C_11975332_10 and
C_8919523_1 (Applied Biosystems) following the
instructions supplied by the manufacturer.
Statistics
Values were expressed as means ± SD. The frequency
distribution of haplotypes and the association of geno-
types with hypertension were analyzed using a chi-
squared test. Comparisons of some indexes between the
EH and NT groups, including SBP, DBP and BMI, were
made using Students’ t-test. To test for an association
between each SNP and hypertension, we computed the
overall genotypic test of association and the three
genetic models (dominant, additive, and recessive).
A multinomial logistic regression was used to study the
effect of E-selectin T1880C, C602A and T1559C variants
on hypertension status to allow incorporation of other
variables into the model. All tests of association were
adjusted for age and gender. Analyses of case-control-
biased haplotype, linkage disequilibrium, and Hardy-
Weinberg equilibrium were performed using SNPAlyze,
version 7.0 Pro (Dynacom Co., Ltd, Mobara, Japan). All
analyses were performed using SPSS v.11.5 (SPSS Inc.,
Chicago, USA) statistical analysis software. A two-tailed
P-value < 0.05 was considered to be statistically signifi-
cant [12].
Results
Genomic locations and related mapping data (Table 1)
were obtained from the National Center for Biotechnol-
ogy Information (NCBI). The basic clinical characteris-
tics of NT and EH groups are listed in Table 2. Age and
sex were matched in the essential hypertensive (EH) and
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total cholesterol (TC), low-density lipoprotein choles-
terol (LDL-C), systolic blood pressure (SBP) and diasto-
lic blood pressure (DBP) were not, but these differences
did not affect the results of analysis. The expected and
observed genotypic frequencies of each SNP were in
good agreement with the predicted Hardy-Weinberg
equilibrium values (data not shown).
A power analysis revealed that, for a = 0.05, our study
had a power to detect differences across cases and con-
trols of 0.85 for the C-carrying genotype of T1880C,
0.93 for the A-carrying genotype of C602A, and 0.89 for
the C-carrying genotype of T1559C. The genotype fre-
quencies of C602A were significantly different (P =
0.005) between EH and NT groups, and the C-allelic
frequency was also significantly different (P = 0.001;
Table 3). A comparison of dominant versus recessive
models (CC + CA vs. AA, or AA + CA vs. CC) revealed
that significant differences persisted (P = 0.004 and P =
0.02 for dominant and recessive models, respectively).
Interestingly, when subgrouped by sex, these indexes
were significantly different in male NT and EH groups,
but not in female NT and EH groups. The additive
model of the T1559C genotype was not different
between EH and NT groups (P = 0.39), but it was differ-
ent between male EH and NT groups (P = 0.046) and
female EH and NT groups (P = 0.045). The CC + TC
versus TT frequency of T1559C was also different in a
recessive model of male EH and NT groups (P = 0.02).
Furthermore, there was a significant interaction between
E-selectin and gender (Pinteraction = 0.02 for C602A
and 0.04 for T1559C), but there was no significant inter-
action between the E-selectin genotypes and other
indexes. As for the SNP T1880C, neither genotype dis-
tribution nor allelic frequency was obviously different
between hypertensive patients and healthy normotensive
subjects.
The variables height, weight, BMI, age, and genotype
showed an association with blood pressure (P < 0.05);
therefore, they were included in a stepwise logistic
regression to study the possible combined effect of
mutant C602A and T1559C alleles and other risk factors
on hypertension. The remaining variables that were clo-
sely associated with BP were BMI, C602A, T1559C,
height and weight after adjusting for age and sex (Table
4). In the haplotype-based case-control analysis, haplo-
types were established in three representative common
SNPs (Table 5). An association with hypertension was
found in the linkage disequilibrium (LD) block (r2 > 0.5,
D’ > 0.9). C602A and T1559C in the block were signifi-
cantly associated with hypertension (P = 0.033 and
P = 0.007, respectively; Figure 1).
For the total population and for males, the C-C-C
haplotype (established from T1880C, C602A and
T1559C) was significantly higher among essential hyper-
tension patients than among control individuals as well
Table 1 Location of SNPs analyzed in the present case-control study
dbSNP rs#cluster ID Contig position Region Function dbSNP allele Protein residue
T1880C/rs5355 20186225 Exon_13 missense T/C Phe/Leu
C602A/rs5361 20191415 Exon_4 missense C/A Tyr/His
T1559C/rs5368 20187301 Exon_9 missense T/C Arg/Ser
Table 2 Clinical characteristics of normotensive and essential hypertensive participants
Index Total Male Female
NT(n = 495) EH(n = 490) P NT(n = 293) EH(n = 316) P NT(n = 202) EH(n = 174) P
Age 51.50 ± 8.92 53.75 ± 7.96 0.85 54.72 ± 5.32 52.1 ± 7.64 0.76 51.50 ± 7.91 52.69 ± 6.88 0.91
BMI (kg/m
2) 22.12 ± 3.12 26.41 ± 3.36 <0.05* 22.1 ± 2.6 24.4 ± 2. 2 0.58 23.9 ± 2.7 27.63 ± 3.05 0.03*
SBP (mmHg) 114.38 ± 11.89 140.29 ± 17.68 <0.01** 106.6 ± 23. 5 142. 4 ± 20. 7 <0.01** 104. 5 ± 24. 1 145.63 ± 19.42 <0.01**
DBP (mmHg) 75.28 ± 9.10 90.44 ± 12.44 <0.01** 80.6 ± 3.7 90.1 ± 10.4 0.01* 72.5 ± 9.6 94.87 ± 11.47 <0.01**
TG(mmol/L) 1.91 ± 0.50 2.03 ± 0.63 0.63 1.07 ± 0. 62 1. 12 ± 0.59 0.72 1.10 ± 0.65 1.32 ± 0.55 0.59
TC(mmol/L) 4.88 ± 1.01 5.38 ± 1.73 <0.05* 4.51 ± 1.22 4.59 ± 1.21 0.93 4.64 ± 1.17 5.36 ± 1.08 <0.05*
HDL-C(mmol/L) 1.62 ± 0.50 1.71 ± 0.61 0.67 0.96 ± 0.73 1.01 ± 0. 32 0.71 1.79 ± 0.31 1.63 ± 0.42 0.64
LDL-C(mmol/L) 1.91 ± 1.79 2.90 ± 1.63 <0.01** 2.08 ± 1.46 2.40 ± 1.48 0.05 2.27 ± 1.41 3.18 ± 1.25 <0.01**
Glu(mmol/L) 4.61 ± 1.45 4.98 ± 1.48 0.78 4.30 ± 1.52 4.40 ± 1.41 0.91 4.60 ± 1.39 4.67 ± 1.74 0.95
BUN(mmol/L) 5.03 ± 1.17 5.89 ± 1.39 0.55 5.08 ± 1.11 6.12 ± 1. 09 0.52 5.02 ± 1.04 5.34 ± 1.22 0.68
Cr(μmol/L) 89.25 ± 15.66 92.05 ± 14.22 0.83 86.23 ± 11.98 90.83 ± 12.12 0.73 87.87 ± 15.57 93.45 ± 12.78 0.54
UA(μmol/L) 86.72 ± 22.46 92.34 ± 17.01 0.69 85.60 ± 20.99 91.48 ± 19.25 0.60 85.79 ± 19.42 90.16 ± 18.77 0.61
All the data were presented as mean ± SD. EH, essential hypertensive patients; NT, normotensive subjects; BMI, body mass index; SBP, systolic blood pressure;
DBP, diastolic blood pressure; TG, triglyceride; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; Glu,
blood glucose; BUN, blood urea nitrogen; Cr, creatinine; UA, uric acid, * P < 0.05, ** P < 0.01.
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Total Male Female
SNPs Genotype NT(n = 495) EH(n = 490) P NT(n = 293) EH(n = 316) P NT(n = 202) EH(n = 174) P
T1880C
Additive TT 2(0.4%) 3(0.6%) 0.44 2(0.7%) 3(0.9%) 0.65 0(0.0%) 0(0.0%) 0.38
TC 48(9.7%) 37(7.6%) 29(9.9%) 25(7.9%) 19(9.4%) 12(6.9%)
CC 445(89.9%) 450(91.8%) 262(89.4%) 288(91.1%) 183(90.6%) 162(93.1%)
Dominant TT + TC 50(10.1%) 40(8.9%) 0.29 31(10.6%) 28(8.9%) 0.47 19(9.4%) 12(6.9%) 0.39
CC 445(89.9%) 450(91.1%) 262(89.4%) 288(91.1%) 183(90.6%) 162(93.1%)
OR 1.26 1.22 1.40
95% CI 0.82-1.96 0.71-2.08 0.66-2.98
Recessive CC + TC 493(99.6%) 487(99.4%) 0.65 291(99.3%) 313(99.1%) 0.72 202(100%) 174(100%) -
TT 2(0.4%) 3(0.6%) 2(0.7%) 3(0.9%) 0 0
OR 1.52 1.40 -
95% CI 0.25-9.13 0.23-8.41 -
Allele T 52(5.3%) 43(4.4%) 0.37 33(5.6%) 31(4.9%) 0.57 19(4.7%) 12(3.4%) 0.39
C 938(94.7%) 937(95.6%) 553(94.4%) 601(95.1%) 385(95.3%) 336(96.6%)
OR 1.21 1.16 0.38
95% CI 0.80-1.83 0.70-1.91 0.66-2.89
C602A
Additive CC 0(0.0%) 5(1.0%) 0.005 0(0.0%) 4(1.3%) 0.01 0(0.0%) 1(0.6%) 0.33
CA 21(4.2%) 38(7.8%) 11(3.8%) 25(7.9%) 10(5.0%) 13(10.6%)
AA 474(95.8%) 447(91.2%) 282(96.2%) 287(90.8%) 192(95.0%) 160(92.0%)
Dominant
CC + CA 21(4.2%) 43(8.8%) 0.004 11(3.8%) 29(9.2%) 0.007 10(5.0%) 14(8.0%) 0.22
AA 474(95.8%) 447(91.2%) 282(96.2%) 287(90.8%) 192(95.0%) 160(92.0%)
OR 0.461 0.386 0.595
95% CI
0.269-0.788
0.189-0.788 0.257-1.376
Recessive
AA + CA 495(100%) 485(99.0%) 0.02 293(100%) 312(98.7%) 0.05 202(100%) 173(99.4%) 0.28
CC 0(0%) 5(1.0%) 0(0%) 4(1.3%) 0(0%) 1(0.6%)
OR 1.010 1.013 1.006
95% CI 1.001-1.019 1.000-1.026 0.994-1.017
Allele
C 21(2.1%) 48(4.9%) 0.001 11(1.9%) 33(5.2%) 0.002 10(2.5%) 15(4.3%) 0.16
A 969(97.9%) 932(95.1%) 575(98.1%) 599(94.8%) 394(97.5%) 333(95.7%)
OR 0.421 0.347 0.563
95% CI 0.250-708 0.174-0.694 0.250-1.271
T1559C
Additive TT 43(8.7%) 33(6.7%) 0.39 30(10.2%) 16(5.1%) 0.046 13(6.4%) 17(9.8%) 0.045
TC 200(40.4%) 191(39.0%) 115(39.2%) 124(39.2%) 85(42.1%) 67(38.5%)
CC 252(50.9%) 266(54.3%) 148(50.5%) 176(55.7%) 104(51.5%) 90(51.7%)
Dominant TT + TC 243(49.1%) 224(45.7%) 0.29 145(49.5%) 140(44.3%) 0.20 98(48.5%) 84(48.3%) 0.96
CC 252(50.9%) 266(54.3%) 148(50.5%) 176(55.7%) 104(51.5%) 90(51.7%)
OR 1.145 1.232 1.010
95% CI 0.892-1.471 0.895-1.694 0.673-1.515
Recessive CC + TC 452(91.3%) 457(93.3%) 0.25 263(89.8%) 300(95.0%) 0.02 189(93.6%) 157(90.2%) 0.23
TT 43(8.7%) 33(6.7%) 30(10.2%) 16(5.0%) 13(6.4%) 17(9.8%)
OR 0.759 0.468 1.574
95% CI 0.474-1.217 0.249-0.877 0.742-3.341
Allele T 286(28.9%) 257(26.2%) 0.19 175(30.0%) 156(24.7%) 0.05 111(27.5%) 101(29.0%) 0.63
C 704(71.1%) 723(73.8%) 415(70.0%) 476(75.3%) 293(72.5%) 247(71.0%)
OR 1.143 1.287 0.926
95% CI 0.938-1.393 0.999-1.657 0.674-1.274
EH, essential hypertensive group; NT, normotensive group; OR, odds ratio; 95%CI, 95% confidence interval.
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0.008 and 0.012). The C-A-T haplotype was higher in
the EH group than in the NT group (P = 0.015) among
males. There were no significant differences in other
haplotypes between the EH and NT groups in males,
females, or over the entire population.
Discussion
Genetics and environmental factors both play very
important roles in the establishment and development
of essential hypertension. Genetics is considered to be
of clinical importance by physicians and researchers in
the pathogenesis, diagnosis, treatment and prevention of
hypertension. With the advent of the human genome
project and the international HapMap project, SNPs
have become increasingly prominent in the study of
both multifactorial and multi-genomic diseases. E-selec-
tin, the product of the SELE gene, is closely associated
with hypertension, coronary heart diseases and athero-
sclerosis, and thus appears to be a risk factor for these
conditions. The gene encoding E-selectin is more
strongly expressed in the plasma of hypertensive
patients than in NT subjects [13,14], and the level of E-
selectin in sedentary, drug-treated hypertensives is sig-
nificantly reduced after lifestyle intervention [15], con-
firming the association of E-selectin with hypertension.
Moreover, Derzbach and colleagues found that the
S128R variant of E-selectin is closely related to severe
preeclampsia [16], and another study reported that the
L554P variant increased the risk of BP in overweight
people [7]. However, to our knowledge, the association
of T1880C, C602A, T1559C E-selectin variants with
essential hypertension has not been previously
investigated.
In this study, we found that the frequency of the gen-
otype C602A was significantly different between hyper-
tensive patients and healthy normotensive subjects (P =
0.005). Moreover, the prevalence of the A allele was
markedly higher in hypertensive patients than in healthy
subjects (OR = 0.42, P = 0.001). Because a significant
association of the SNP C602A with essential hyperten-
sion was obtained in a multivariate analysis after adjust-
ing for confounding risk factors, including age, body
weight and height, the A allele of C602A may be an
independent risk factor for hypertension. Grouping the
subjects in this study by sex revealed that males exhib-
ited a similar association with essential hypertension,
whereas females did not, possibly indicating that C602A
is more significantly associated with hypertension in
males. On the basis of these results, we conclude that
C602A is associated with hypertension. The frequency
of the T1559C SNP was also significantly different
between normotensive subjects and hypertensive
patients when grouped by sex. A multivariate analysis,
applied as described above, also indicated an association
between T1559C and hypertension.
Haplotype analysis is considered a good method for
studying the genetics of complex diseases while avoiding
problems incurred by multiple testing. In this study, two
haplotypes of E-selectin were significantly associated
with essential hypertension. Moreover, a power analysis
revealed that, for a = 0.05, our study had the power to
detect differences across cases and controls of 0.93 for
the A-carrying genotype of C602A, and 0.89 for the
C-carrying genotype of T1559C. Furthermore, the distri-
bution of all polymorphisms was in Hardy-Weinberg
equilibrium (data not shown), suggesting that the results
of this study are unlikely to be biased by population
stratification or admixture for essential hypertension.
Taken together, our data strongly suggest that C602A
and T1559C are associated with essential hypertension.
The potential mechanism by which the common SNPs
Table 4 Results of multiple logistic regression analysis:
final significant variables in equation
Risk Factor Wald c
2 P OR 95% C.I
BMI 30.73 <0.01 0.80 0.74-0.87
C602A 5.69 <0.01 7.58 1.53-11.97
T1559C 6.12 <0.05 6.77 1.07-1.83
Height 9.51 <0.01 1.07 1.02-1.11
Weight 27.93 <0.01 0.92 0.90-0.95
BMI, body mass index; OR, odds ratio; 95%CI, 95% confidence interval.
Table 5 Haplotype analysis in normotensive and essential hypertensive participants
Haplotype Total Male Female
T1880C C602A T1559C EH
(n = 490)
NT
(n = 495)
PE H
(n = 316)
NT
(n = 293)
PE H
(n = 174)
NT
(n = 202)
P
H1 G T G 0.66 0.64 0.43 0.66 0.63 0.17 0.64 0.66 0.60
H2 G T A 0.25 0.29 0.10 0.24 0.30 0.02 0.28 0.27 0.68
H3 A T G 0.04 0.05 0.28 0.04 0.05 0.34 0.03 0.04 0.40
H4 G G G 0.04 0.02 0.008 0.05 0.02 0.01 0.03 0.02 0.36
H5 G G A 0.008 0.002 0.16 0.006 0.003 0.09 0.009 0.004 0.46
H6 A T A 0.002 0.002 0.92 0.003 0.005 0.82 0.004 0.004 0.80
EH, essential hypertensive patients; NT, normotensive subjects.
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hypertension remains unknown. Because these two
SNPs are located in exons and the variants exhibit
changes in amino acidic residues, it is possible that the
resulting proteins promote enhanced phagocyte and/or
adhesive activity of the endothelium and provoke
inflammation in the vascular wall–a characteristic of
hypertension [17]. Endothelium damage and dysfunction
and disturbance of endothelially derived vasomodulatory
factors may be another explanation [18]. However, addi-
tional studies will be required.
The minor allele frequencies (MAF) of the three SNPs
in this study, T1880C(5.3%):C602A(2.1%):T1559C
(28.9%), differed from the values reported in the NCBI
SNP database T1880C(1.1%):C602A(1.1%):T1559C
(32.6%) submitted by HapMap project (http://www.ncbi.
nlm.nih.gov/projects/SNP/snp_viewTable.cgi?pop=1410).
Because population distribution and sample size are very
important determinants of MAF, it is likely that the
small sample size in the HapMap project (n = 45) com-
pared to the larger sample size (n = 495) in our study,
and differences in the population distribution (indivi-
duals living in the residential community at Beijing Nor-
mal University in the HapMap project vs. Beijingers in
our study) are responsible for the MAF difference
between the HapMap project and our study.
The present population-based, case-control study also
showed significant gender-specific (male only) differences
in genetic markers between essential hypertension patients
and control individuals. Moreover, we noted a significant
gene-by-gender interaction with BP traits in this study.
Several studies have reported gender-specific effects of
gene variants and gene-by-gender interactions in human
hypertension [19-22]. These data support our findings.
One potential mechanism by which two common SNPs
(C602A and T1559C) might contribute to essential hyper-
tension in males is that these two variants increase
susceptibility to endothelial dysfunction, inflammation and
atherosclerosis. Although this is consistent with the fact
that males have higher incidences of essential hyperten-
sion than females [23], more studies were needed. As for
SNP T1880C, both genotypes and alleles exhibited similar
frequencies in hypertensive patients and healthy normo-
tensive subjects, even after adjusting for age and sex.
Certain limitations in the population under study lead
to an increased risk of overestimating the statistical sig-
nificance of MAFs. Accordingly, to enhance the reliabil-
ity of conclusions, future studies should strive to achieve
a more representative population distribution, larger
sample sizes, a wider age distribution, and different
blood pressure range subgroups.
Conclusion
This study provides new evidence in support of an asso-
ciation between E-selectin and hypertension, showing
that C602A and T1559C polymorphisms of E-selectin
are novel candidate essential hypertension-associated
SNPs, whereas T1880C is not. Future studies might
explore these associations in different ethnic groups and
investigate the mechanisms by which the C602A and
T1559C polymorphisms of E-selectin might lead to
hypertension.
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